SPOTLIGHT -
Case-Based Psych Perspectives: Treating Schizophrenia in the Era of COVID-19
This article provides a summary of key points discussed in a Case-Based Psych Perspectives Series, shared by Bryce Reynolds, MD, and Hannah Phillips-Hall, MSN, PMHNP-BC.
Advice for Treating Schizophrenia During COVID-19
Motivating Patients With Schizophrenia to Initiate an LAI
Frequency of Long-Acting Injectable Agents for Schizophrenia
APA Guidelines for the Treatment of Schizophrenia With LAIs
Challenges and Unmet Needs When Treating Schizophrenia
The Benefits of Long-Acting Injectables for Schizophrenia
Transitioning to Long-Acting Injectables in Schizophrenia
New Diagnosis of Schizophrenia Initiated on Long-Acting Injectable
